-
公开(公告)号:US20140100225A1
公开(公告)日:2014-04-10
申请号:US14046682
申请日:2013-10-04
IPC分类号: C07D401/04 , A61K31/095 , A61K31/5377 , C07C309/04 , A61K31/506 , A61K45/06
CPC分类号: A61K31/506 , A61K31/095 , A61K31/5377 , A61K45/06 , C07C309/04 , C07D401/04 , Y02A50/475
摘要: Novel compounds and their synthesis are described. Methods for using these compounds in the prevention or treatment of cancer, a bacterial infection or a viral infection in a subject are also described.
摘要翻译: 描述了新型化合物及其合成。 还描述了使用这些化合物预防或治疗受试者中的癌症,细菌感染或病毒感染的方法。
-
公开(公告)号:US10752589B2
公开(公告)日:2020-08-25
申请号:US16085125
申请日:2017-03-14
发明人: Sundeep Dugar , Dinesh Mahajan , Somdutta Sen
IPC分类号: C07D213/80 , C07D213/02 , C07D401/14 , C07D405/14 , C07D405/12 , C07D471/14 , C07D401/12 , C07D407/14 , A61K31/337
摘要: The present invention provides novel compounds with improved solubility and altered pharmacokinetic properties. The compounds of the present invention may be represented by Formula (I).
-
公开(公告)号:US10100012B2
公开(公告)日:2018-10-16
申请号:US15313986
申请日:2015-06-01
IPC分类号: C07D211/42 , C07D211/56 , C07D211/58 , A61K31/445 , A61K45/06
摘要: The present invention relates to novel compounds of formula (1): The present invention also discloses compounds of formula (1) along with other pharmaceutical acceptable excipients and use of the compounds as anti-tubercular agents.
-
公开(公告)号:US10207993B2
公开(公告)日:2019-02-19
申请号:US15674033
申请日:2017-08-10
IPC分类号: A61K45/06 , A61K31/445 , C07D205/04 , C07D207/09 , C07D207/12 , C07D211/42 , C07D211/46 , C07D211/56 , C07D211/58 , C07D213/75 , C07D265/30 , C07D453/04 , C07C59/64
摘要: The present invention relates to novel compounds of formula (1): The present invention also discloses compounds of formula (1) along with other pharmaceutical acceptable excipients and use of the compounds as anti-tubercular agents.
-
公开(公告)号:US09556140B2
公开(公告)日:2017-01-31
申请号:US14763018
申请日:2014-01-27
IPC分类号: C07D311/62 , A61K31/353 , C07D311/30 , C07D311/32 , C07F7/18
CPC分类号: C07D311/62 , A61K31/353 , C07D311/30 , C07D311/32 , C07F7/1804
摘要: A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+ and/or −) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-protected quercetin obtained from step (i); (iii) optionally deprotecting the compound of step (ii); (iv) reducing the compound obtained from step (ii) or step (iii) in the presence of a chiral/achiral reducing agent to obtain a chiral intermediate; (v) deprotecting and/or hydrogenation of the chiral intermediate obtained from step (iv) to obtain (−)-epicatechin; (vi) optionally simultaneously deprotecting and by drogenation of the compound obtained from step (ii) to obtain racemic epicatechin.
摘要翻译: (+和/或 - )表儿茶素及其中间体的对映体纯的或对映体富集或外消旋混合物的方法,包括以下步骤:(i)获得五保护的槲皮素; (ii)还原由步骤(i)获得的五保护的槲皮素; (iii)任选地使步骤(ii)的化合物脱保护; (iv)在手性/非手性还原剂存在下还原由步骤(ii)或步骤(iii)获得的化合物,得到手性中间体; (v)从步骤(iv)获得的手性中间体的脱保护和/或氢化得到( - ) - 表儿茶素; (vi)任选地同时去除由步骤(ⅱ)获得的化合物脱保护和脱氢,得到外消旋表儿茶素。
-
公开(公告)号:US09975869B2
公开(公告)日:2018-05-22
申请号:US14780214
申请日:2014-04-04
IPC分类号: C07D311/62 , C07D311/60 , C07C45/71 , C07C45/72 , C07D311/54 , C07D405/12 , A23L33/10
CPC分类号: C07D311/62 , A23L33/10 , C07C45/71 , C07C45/72 , C07D311/54 , C07D311/60 , C07D405/12
摘要: The present invention provides novel analogs of epicatechin and related polyphenols, their variously functionalized derivatives, process for preparation of the same, composition comprising these compounds and their method of use.
-
公开(公告)号:US20150368223A1
公开(公告)日:2015-12-24
申请号:US14763018
申请日:2014-01-27
IPC分类号: C07D311/62 , C07F7/18 , C07D311/30
CPC分类号: C07D311/62 , A61K31/353 , C07D311/30 , C07D311/32 , C07F7/1804
摘要: A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or−) epicatechin echm and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-protected quercetin obtained from step (i); (iii) optionally deprotecting the compound of step (ii); (iv) reducing the compound obtained from step (ii) or step (iii) in the presence of a chiral/achiral reducing agent to obtain a chiral intermediate; (v) deprotecting and/or hydrogenation of the chiral intermediate obtained from step (iv) to obtain (−)-epicatechin; (vi) optionally simultaneously deprotecting and by drogenation of the compound obtained from step (ii) to obtain racemic epicatechin.
摘要翻译: (+和/或)表儿茶素echm及其中间体的对映体纯的或对映体富集或外消旋混合物的方法,包括以下步骤:(i)获得五保护的槲皮素; (ii)还原由步骤(i)获得的五保护的槲皮素; (iii)任选地使步骤(ii)的化合物脱保护; (iv)在手性/非手性还原剂存在下还原由步骤(ii)或步骤(iii)获得的化合物,得到手性中间体; (v)从步骤(iv)获得的手性中间体的脱保护和/或氢化得到( - ) - 表儿茶素; (vi)任选地同时去除由步骤(ⅱ)获得的化合物脱保护和脱氢,得到外消旋表儿茶素。
-
公开(公告)号:US20150252027A1
公开(公告)日:2015-09-10
申请号:US14433485
申请日:2013-10-07
IPC分类号: C07D405/14 , C07D471/14 , C07D401/14
CPC分类号: C07D405/14 , C07D213/82 , C07D401/14 , C07D471/14 , C07D487/04
摘要: The present invention discloses novel chemical compounds obtained by causing a covalent attachment of a modifying agent of the structure provided for formula 1, to a functional group or a heteroatom of a heterocyclic ring system in chemical compound with improved chemical and biological properties. Wherein: Y is DRUG-CO; DRUG-OCO; DRUG-NRCO, and X is selected from.
摘要翻译: 本发明公开了通过使具有式1的结构的改性剂共价连接到具有改进的化学和生物学特性的化合物中的杂环体系的官能团或杂原子而获得的新型化合物。 其中:Y为DRUG-CO; DRUG-OCO; DRUG-NRCO,X选自。
-
公开(公告)号:US09630958B2
公开(公告)日:2017-04-25
申请号:US14416140
申请日:2013-07-23
发明人: Sundeep Dugar , Dinesh Mahajan , Frank Hollinger Peter , Amit Sharma , Vinayak Tripathi , Bilash Kuila
IPC分类号: C07D413/14 , C07D401/04 , C07D403/04 , A61K31/53 , A61K31/5377 , A61K31/4427 , A61P35/00 , C07D417/14 , C07D401/14 , C07D413/04 , C07D417/04 , C07D471/04 , C07D491/08 , C07D498/08
CPC分类号: C07D417/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04 , C07D491/08 , C07D498/08
摘要: The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical acceptable excipients and use of the compounds to modulate the PI3K/mTOR pathway.
-
公开(公告)号:US20150197515A1
公开(公告)日:2015-07-16
申请号:US14416140
申请日:2013-07-23
发明人: Sundeep Dugar , Dinesh Mahajan , Frank Hollinger Peter , Amit Sharma , Vinayak Tripathi , Bilash Kuila
IPC分类号: C07D417/14 , C07D401/04 , C07D417/04
CPC分类号: C07D417/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04 , C07D491/08 , C07D498/08
摘要: The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical acceptable excipients and use of the compounds to modulate the PI3K/mTOR pathway.
摘要翻译: 本发明涉及式(1)的新型三嗪化合物。 本发明还公开了式I化合物以及其它药学上可接受的赋形剂以及该化合物用于调节PI3K / mTOR途径的用途。
-
-
-
-
-
-
-
-
-